Dr. Reddy’s introduces generic version of Dacogen in US

Following the approval by the USFDA of Dr. Reddy’s ANDA for Decitabine for Injection 50mg is available as a single dose vial.

Decitabine that belongs to a class of medications called hypomethylation agents works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.

Myelodysplastic syndrome is a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells.

The sales of Dacogen brand in the US were approximately $260m MAT for the most recent twelve months ending in July 2013, according to IMS Health data.